In addition, compared with the reference group, those with elevated ET‐1 levels had a noticeably higher risk of non‐fatal myocardial infarction (adjusted HR, 2.203; 95% CI, 1.018–4.764, p < 0.001). This evidence concerns the gene EDN1 and myocardial infarction.